2006
DOI: 10.1074/jbc.m508527200
|View full text |Cite
|
Sign up to set email alerts
|

Membrane-associated STAT3 and PY-STAT3 in the Cytoplasm

Abstract: Signal transduction from the plasma membrane to the nucleus by STAT proteins is widely represented as exclusively a soluble cytosolic process. Using cell-fractionation methods, we observed that ϳ5% of cytoplasmic STAT3 was constitutively associated with the purified early endosome (EE) fraction in human Hep3B liver cells. By 15-30 min after interleukin-6 (IL-6) treatment, up to two-thirds of cytoplasmic Tyr-phosphorylated STAT3 can be associated with the purified early endosome fraction (Rab-5-, EEA1-, transfe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

9
123
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 72 publications
(132 citation statements)
references
References 60 publications
9
123
0
Order By: Relevance
“…The following constitutive expression constructs were used in our studies: 1) N1-EGFP and STAT3-EGFP from Dr. Taddaki Miyazaka, Hokkaido University, Sapporo, Japan (54); 2) dominantnegative (DN) dynamin II K44A (Dyn II K44A) from Dr. Lois Greene, National Institutes of Health (NIH), Bethesda, MD (55); 3) murine cav-1 wild-type (WT) from Dr. Ferruccio Galbiati, University of Pittsburgh, Pittsburgh, PA (52); 4) myc-tagged canine cav-1-WT and cav-1-S80A-myc and cav-1-S80E-myc, which are single point mutations in the scaffolding domain of cav-1 from Dr. Jeffery Pessin, SUNY Stony Brook, Stony Brook, NY (48); 5) a myc-tagged double point mutation in the scaffolding domain of cav-1 (canine species) cav-1-F92A/V94A and the corresponding myc-tagged cav-1-WT from Dr. Michael Quon, NIH (30); 6) human GRP58-WT from Drs. Mohammed Bourdi and Lace Pohl, NIH (8); and 7) p950M4-luciferase, a well-characterized STAT3 responsive luciferase construct, which contains four copies of STAT3 DNA-binding element from the human angiotensin promoter from Dr. Ashok Kumar, New York Medical College, Valhalla, NY (26,46).…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…The following constitutive expression constructs were used in our studies: 1) N1-EGFP and STAT3-EGFP from Dr. Taddaki Miyazaka, Hokkaido University, Sapporo, Japan (54); 2) dominantnegative (DN) dynamin II K44A (Dyn II K44A) from Dr. Lois Greene, National Institutes of Health (NIH), Bethesda, MD (55); 3) murine cav-1 wild-type (WT) from Dr. Ferruccio Galbiati, University of Pittsburgh, Pittsburgh, PA (52); 4) myc-tagged canine cav-1-WT and cav-1-S80A-myc and cav-1-S80E-myc, which are single point mutations in the scaffolding domain of cav-1 from Dr. Jeffery Pessin, SUNY Stony Brook, Stony Brook, NY (48); 5) a myc-tagged double point mutation in the scaffolding domain of cav-1 (canine species) cav-1-F92A/V94A and the corresponding myc-tagged cav-1-WT from Dr. Michael Quon, NIH (30); 6) human GRP58-WT from Drs. Mohammed Bourdi and Lace Pohl, NIH (8); and 7) p950M4-luciferase, a well-characterized STAT3 responsive luciferase construct, which contains four copies of STAT3 DNA-binding element from the human angiotensin promoter from Dr. Ashok Kumar, New York Medical College, Valhalla, NY (26,46).…”
Section: Methodsmentioning
confidence: 99%
“…Recombinant human IL-6 (R&D Systems, Minneapolis, MN) was used at 10 ng/ml for 30 min unless otherwise specified (24,25,29,39). Phenylarsine oxide (PAO) was from Sigma-Aldrich (St. Louis, MO) and was used at 5 M for 30 min (46).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations